In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avoiding CER Redundancy: PCORI Members Seek Transparency On How AHRQ Spends Its Portion Of Funding

Executive Summary

Patient-Centered Outcomes Research Institute board member Leah Hole-Curry calls for more transparency in how the Agency for Healthcare Research and Quality is spending its portion of the PCORI budget, so that the groups can avoid making redundant efforts. The board debates how best to determine the success of efforts to disseminate research information.

You may also be interested in...



Making CER Findings Relevant Requires Putting Results In Context – PCORI Board

As the Patient-Centered Outcomes Research Institute board of governors debates its approach to disseminating and implementing research findings, one component is clear: context of research in the lives of those who will use it needs to be a key focus.

Vague PCORI Agenda Makes Commenting On Funding Allocations Difficult

Comments on the Patient-Centered Outcomes Research Institute’s national priorities and research agenda reveal difficulty in expressing thoughts on how the institute should allocate its research funds due to a lack of specificity in the research agenda itself.

Mammogram Recommendations Show Perils Of Communicating CER Results

The controversy surrounding the recent recommendations on mammogram screenings by the U.S. Preventive Services Task Force has the potential to be played out again amid the continued push for more comparative effectiveness research

Topics

Related Companies

UsernamePublicRestriction

Register

PS054139

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel